Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study

Overview of attention for article published in Breast Cancer Research and Treatment, October 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 75 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 516 followers.

NEW article 19/10/2016: https://t.co/wY7aCX3jNX

Reply Repost Favourite